Member Info for HeidHoncho

Part of a post of your’s from the 26th.

“ By all means people jump in and out if you need to, but there's no need to keep updating the BB on your trades. “

Don’t do as I do, do as I say, philosophy adopted there.

Alba, isn’t there 360 million shares in issue, not merely 29 million ?

What was in EMH’s quarterly report that caused such a drop in their SP I wonder.

My mistake, I miscounted the number of trading days that had passed.

In that case then, if the warrant holders do not want to be pressed at this moment in time to utilise their warrants then they will need to ensure that the sp doesn’t close at 16p or greater at any point in time over the next 6 trading days.

I take it that now the conditions for the warrant accelerator have been met that this will now kick in, and the warrant holders from the recent placing will have up to 7 days to cough up the cash or have their warrants cancelled.

From the figures detailed in the RNS today I am struggling to get things to add up.

How come on the 17th July EMH issuing 1,049,826 shares equated to a 1.04% reduction in KDNC’s holdings, yet on the 17th September, when EMH issued a mere 50,000 shares that equated to a 0.97% reduction in KDNC’s holding.

Can someone explain why the significant differential in new shares being issued resulted in an almost similar reduction in KDNC’s shareholding in EMH ?

Or is it that they are only reporting EMH share issuance instances whereupon that had a consequential effect that it brought KDNC’s shareholding through a reporting point ?

“On 17/07/2020 and as a result of the issue of 1,049,826 shares in European Metals Holdings Limited, Cadence Minerals PLC voting rights decreased to 14.93%.”



“On 17/09/2020 and as a result of the issue of 50,000 shares in European Metals Holdings Limited, Cadence Minerals PLC voting rights decreased to 13.96%.”

“ ... the appeal will grant ukog costs which will far exceed the costs ...” ?

Comedy gold.

Does this mean then, that in the JV areas that the new distribution will be KDNC 30%, BCN 35%, and Ganfeng 35% ?

Why would they require an ROV to retrieve the Metrol gauges ?

I thought that the Metrol gauge data recovery could be retrieved acoustically, i.e. no requirement for physical recovery of the gauges to surface.

IMHO

‘charterer” not “chartered” ............ bleeding autocorrect.

I thought demurrage was payable by the chartered of the vessel.

I further thought we were selling the product on FOB Incoterms.

Ergo, not the vessel charterer, and therefore not liable for the demurrage.

Though I’m sure if there are any errors in my assumption, and someone has verifiable information to the contrary, then someone will identify the error of my ways.

I just checked my files, yes it does have ROV capability, though that doesn’t mean that it will be getting deployed in that role in this instance.

Although the Skandi Hera could provide a supply function it is predominantly utilised in its primary role as an AHTS.

No telling why it may be there, but I doubt it will be getting utilised for resupply of the Aoka Mizu, I would anticipate that it would be more likely performing a sub sea role, or perhaps being utilised for data acquisition (gauge data recovery, etc.).

Will need to check my files later to see if the Skandi Hera has ROV capability, if it does then that opens up a myriad of other potential reasons that it may be there.

IMHO.

Just for accuracy and correction, at £3 per share the market cap would be north of £175 million.

There is currently no chance of obtaining a share certificate, so it is a mute point.

That’s the beauty about insolvency, it is not an opinion based metric, it is a black or white fact based determination..

LL, I was watching an article on CNN tonight about the success, or otherwise, of the Swedish herd immunity process.

Although they are currently showing a low mortality, they had high hopes that the population now would be showing a high immunity rate, but when testing the population to see the level of antibodies they were carrying they were disappointed to find that only circa 6% (it may have been 9% however, as I wasn’t paying full attention at that time).

There was then a section where a guy came on from an institution (I don’t know if it was Marcus Buggert), who intimated that although the standard tests for identifying antibodies were showing low results that these results may be significantly underestimating the level of immunity that there actually is in the population, as the T-cell activity that they had been investigating bore witness to the likelihood that immunity levels may be significantly higher than is currently being identified under the standard means.

Were these investigations into T-cell activity to be confirmed as being a truer level of herd immunity than that being shown under standard antibody testing, it is logical to assume that the interest level in companies who are at the forefront of T-cell research would greatly increase.

Whether that would bring any interest to bare on the work that SCLP have/are/will be conducting into the T-cell sphere is open to conjecture, but it is certainly a positive.

IMHO

has made a higher probability however is that the vesting requirements for the company to invoke the warrants to be purchased will likely be met.

If the SP does not drop by circa 35% between now and close of business on Monday, then the vesting terms will have been met.

Not a banker, but it now has a greater probability.

Only time will tell for sure.

With a guarantee that your initial capital is protected ?

Is the VAL agreement solely in regards to their VAL201 product, or does it also include their VAL301 and VAL401 product line ?